Antibiotic Indications for Acute Pharyngitis
Antibiotics are indicated for acute pharyngitis only when Group A β-hemolytic Streptococcus (GAS) infection is confirmed by microbiological testing—either rapid antigen detection test (RADT) or throat culture—regardless of patient history, as clinical features alone cannot reliably distinguish bacterial from viral pharyngitis. 1
Diagnostic Approach: Who Needs Testing?
The decision to test for GAS should be guided by clinical scoring systems rather than testing all patients with sore throat:
McIsaac/Centor Scoring System 1
Calculate points based on:
+1 point each for:
- Temperature ≥38°C (100.4°F)
- Absence of cough
- Tender anterior cervical lymphadenopathy
- Tonsillar swelling or exudate
- Age <15 years
-1 point for:
- Age ≥45 years
Testing Strategy Based on Score 1, 2
- Score 0-1: No testing or antibiotics needed—viral etiology most likely
- Score 2-3: Perform RADT; treat only if positive
- Score 4+: Either perform RADT and treat if positive, OR treat empirically based on clinical grounds
Important caveat: Children under 3 years rarely develop GAS pharyngitis and typically do not require testing, as acute rheumatic fever is exceedingly rare in this age group 1. The vast majority of pharyngitis cases (75-90% in adults, 60-75% in children) are viral and do not benefit from antibiotics 1.
Microbiological Confirmation Requirements
Rapid Antigen Detection Tests (RADT) 1
- Positive RADT: Treat immediately with antibiotics 1
- Negative RADT in children/adolescents: Confirm with throat culture due to imperfect sensitivity (typically 80-90%) 1
- Negative RADT in adults: Culture backup generally not needed due to low disease prevalence and minimal rheumatic fever risk 1
Throat Culture 1
- Remains the gold standard with highest sensitivity
- Results take 24-48 hours, but treatment can be safely delayed up to 9 days after symptom onset and still prevent acute rheumatic fever 3
- Not routinely needed for post-treatment follow-up in asymptomatic patients 1
Special Populations Requiring Different Thresholds
Patients with History of Rheumatic Fever 1, 4
These patients warrant immediate antibiotic treatment for any confirmed GAS pharyngitis, as they face exceptionally high risk (up to 50%) of recurrent rheumatic fever with subsequent GAS infections. 1 Additionally, they require continuous antimicrobial prophylaxis (secondary prevention) rather than episodic treatment alone:
- Duration of prophylaxis: 10 years or until age 40 (whichever is longer) for those with residual heart disease; potentially lifelong in severe cases 1
- Prophylaxis regimen: Benzathine penicillin G 1.2 million units IM every 3-4 weeks, or penicillin V 250 mg orally twice daily 1, 4
Immunocompromised Patients 2
While the provided guidelines focus primarily on immunocompetent patients, those with immunocompromise warrant a lower threshold for testing and treatment due to increased risk of suppurative complications (peritonsillar abscess, cervical lymphadenitis, bacteremia). However, the same diagnostic principles apply—confirm GAS before treating 2.
Primary Goals of Antibiotic Treatment
When GAS is confirmed, antibiotics serve multiple purposes 1:
- Prevention of acute rheumatic fever (most critical in developing countries and certain regions; rare in industrialized nations but still the primary justification) 1
- Reduction of suppurative complications (peritonsillar abscess, cervical adenitis—though these occur in only ~1% of cases even without treatment) 1
- Symptom resolution (shortens illness by approximately 1 day) 1
- Reduced transmission to close contacts 1
Critical note: Antibiotics do NOT prevent post-streptococcal glomerulonephritis 1. This non-suppurative complication occurs regardless of treatment.
First-Line Antibiotic Regimens
For Penicillin-Tolerant Patients 1, 5, 4, 6
Penicillin V: 500 mg orally twice daily (or 250 mg four times daily) for 10 days in adults; 250 mg 2-3 times daily in children <27 kg 1, 5, 4
Amoxicillin: 500 mg orally twice daily for 10 days in adults; 50 mg/kg once daily (maximum 1000 mg) for 10 days in children—equally effective as penicillin V with better palatability and compliance 1, 5, 6, 7
Benzathine penicillin G: 1.2 million units IM as single dose (600,000 units if <27 kg)—preferred when adherence to oral therapy is unlikely 1, 5
The 10-day duration is non-negotiable for all oral antibiotics except azithromycin, as shorter courses dramatically increase treatment failure rates and rheumatic fever risk. 1, 3, 5
For Penicillin-Allergic Patients 1, 3, 5
The choice depends on the type of allergic reaction:
Non-Immediate (Non-Anaphylactic) Allergy 1, 3
First-generation cephalosporins are preferred:
- Cephalexin: 500 mg orally twice daily for 10 days (adults); 20 mg/kg/dose twice daily for 10 days (children) 1, 3
- Cefadroxil: 1000 mg orally once daily for 10 days (adults); 30 mg/kg once daily for 10 days (children) 1, 3
Cross-reactivity risk is only 0.1% with non-immediate penicillin reactions 3.
Immediate/Anaphylactic Allergy 1, 3, 5
Avoid ALL beta-lactams (including cephalosporins) due to up to 10% cross-reactivity risk. 1, 3
Preferred alternatives:
Clindamycin: 300 mg orally three times daily for 10 days (adults); 7 mg/kg/dose three times daily for 10 days (children, maximum 300 mg/dose)—only ~1% resistance rate in the US and highly effective even in chronic carriers 1, 3, 5
Azithromycin: 500 mg orally once daily for 5 days (adults); 12 mg/kg once daily for 5 days (children, maximum 500 mg)—convenient 5-day course due to prolonged tissue half-life, but 5-8% macrolide resistance in the US 1, 3, 5
Clarithromycin: 250 mg orally twice daily for 10 days (adults); 7.5 mg/kg/dose twice daily for 10 days (children, maximum 250 mg/dose)—similar resistance concerns as azithromycin 1, 3
Common Pitfalls to Avoid
Testing and Treatment Errors 1, 8
- Never treat pharyngitis with antibiotics without microbiological confirmation (RADT or culture)—70-90% of cases are viral
- Never use clinical features alone to diagnose GAS pharyngitis—even experienced clinicians cannot reliably distinguish bacterial from viral causes
- Never perform routine post-treatment testing in asymptomatic patients who completed therapy—up to 20% may be chronic carriers with positive tests but no active infection 1, 8
- Never use sulfonamides, trimethoprim-sulfamethoxazole, tetracyclines, or fluoroquinolones for GAS pharyngitis—these agents are ineffective 1, 5
Duration and Compliance Issues 1, 3, 5
- Never shorten antibiotic courses below 10 days (except azithromycin's 5-day regimen)—even a few days' reduction substantially increases treatment failure and rheumatic fever risk
- Never assume all penicillin-allergic patients need non-beta-lactam antibiotics—most can safely receive first-generation cephalosporins if the allergy was non-immediate 3
Carrier State Confusion 1, 8
- Chronic GAS carriers (up to 20% of school-age children in winter/spring) have positive tests but no immunologic response to the organism
- Carriers experiencing viral pharyngitis will test positive for GAS but don't benefit from antibiotics
- Carriers are at minimal risk for complications and rarely spread infection to contacts 1, 8
- Do not routinely treat carriers—they only need treatment if they develop true symptomatic GAS pharyngitis with rising anti-streptococcal antibody titers 1
When Antibiotics Are NOT Indicated
Do not prescribe antibiotics for: 1, 2
- Pharyngitis with negative RADT/culture
- Patients with 0-1 Centor/McIsaac criteria (very low GAS probability)
- Asymptomatic household contacts of GAS cases (unless outbreak situation)
- Chronic carriers without evidence of acute infection
- Pharyngitis clearly due to other pathogens (Group C/G streptococci, viral agents, Epstein-Barr virus)
The overwhelming majority of acute pharyngitis is self-limited viral illness requiring only supportive care with analgesics, antipyretics, adequate hydration, and rest 1. Antibiotic overuse in pharyngitis is a major driver of antimicrobial resistance and unnecessary adverse effects. 1